


Ferla Romain
Romain Ferla is an Antitrust/Competition partner in Weil, Gotshal & Manges’ Paris office. Mr. Ferla has significant experience in European Union and French competition law matters, including merger control, investigation of cartels or abuses of dominance, and advising on distribution agreements (containing vertical restraints), cooperation agreements with joint ventures, and state aids and state measures distorting competition. Mr. Ferla’s successful track record in antitrust litigation includes defending and representing a wide range of clients before French courts and in administrative proceedings before the European Union and French competition authorities. He has served both as counsel to the notifying parties (private equity funds and corporate clients) and as counsel to the complainants. Romain’s recent transactions include pre-merger review of Oaktree’s acquisition of Nord Est Ileos ; Axa Private Equity’s acquisition of the Fives Group ; Marinopoulos’ acquisition of Carrefour’s 50% stake in Carrefour Marinopoulos ; Axa Private Equity’s joint bid (with Chinese conglomerate Fosun) on Club Méditerranée. All these transactions involved multi-jurisdictional filings. Romain Ferla has been recognized as “Rising Star” for EU competition and distribution in France in Legal 500 2013.
Auteurs associés
1365 | Évènements

Articles
2390 Bulletin
2390
French courts are more and more solicited by suppliers claiming that online resellers or platforms violate their selective and/or exclusive distribution networks. We all remember the decisions recently rendered by the Paris commercial court in favour of LVMH against ebay . In a similar case, (...)
2822 Revue
2206
L’effet suspensif du contrôle des concentrations n’est pas un principe absolu. Tant l’Autorité de la concurrence que la Commission européenne reconnaissent l’existence de dérogations exceptionnelles à ce principe. En temps de crise, les demandes de dérogations se font plus nombreuses, la crise (...)
616
Alors que l’Autorité de la concurrence vient de rendre sa première décision d’autorisation conditionnelle dans le secteur des soins hospitaliers, il est intéressant de se pencher sur les expériences étrangères de contrôle des concentrations dans ce secteur si particulier et si sensible. Le présent (...)
Livres
